| Dr Murali Macherla, MD | |
|
13640 N 99th Ave Ste 400, Sun City, AZ 85351-2867 | |
| (602) 999-9999 | |
| (480) 393-1970 |
| Full Name | Dr Murali Macherla |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 38 Years |
| Location | 13640 N 99th Ave Ste 400, Sun City, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750487153 | NPI | - | NPPES |
| WCSKQ | Other | AZ | SUN HEALTH GROUP # |
| 219431 | Medicaid | AZ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Scottsdale Osborn Medical Center | Scottsdale, AZ | Hospital |
| Arrowhead Hospital | Glendale, AZ | Hospital |
| Honorhealth Scottsdale Shea Medical Center | Scottsdale, AZ | Hospital |
| Scottsdale Thompson Peak Medical Center | Scottsdale, AZ | Hospital |
| Entity Name | Pulse Cardiovascular Institute Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730675547 PECOS PAC ID: 4587903364 Enrollment ID: O20190222002363 |
News Archive
Since the novel coronavirus SARS-Cov-2 emerged late last year, it has been virtually impossible to consume any news without encountering stories about the virus and how it spreads, potential treatments, and the development of new vaccines.
A type of anti-bacterial T cells, so-called MAIT cells, are strongly activated in people with moderate to severe COVID-19 disease, according to a study by researchers at Karolinska Institutet in Sweden that is published in the journal Science Immunology. The findings contribute to increased understanding about how our immune system responds against COVID-19 infection.
Medtronic plc announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the EvolveSM workflow*, which standardizes guidance and balances high-dose (HD) and low-dose (LD) therapy settings.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Researchers at the University of Sheffield have found that parks rich in species are not only beneficial for the environment but also for people's general well-being.
› Verified 6 days ago
| Entity Name | Arizona Chest And Vascular Surgeons Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255946000 PECOS PAC ID: 2365854171 Enrollment ID: O20201221001886 |
News Archive
Since the novel coronavirus SARS-Cov-2 emerged late last year, it has been virtually impossible to consume any news without encountering stories about the virus and how it spreads, potential treatments, and the development of new vaccines.
A type of anti-bacterial T cells, so-called MAIT cells, are strongly activated in people with moderate to severe COVID-19 disease, according to a study by researchers at Karolinska Institutet in Sweden that is published in the journal Science Immunology. The findings contribute to increased understanding about how our immune system responds against COVID-19 infection.
Medtronic plc announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the EvolveSM workflow*, which standardizes guidance and balances high-dose (HD) and low-dose (LD) therapy settings.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Researchers at the University of Sheffield have found that parks rich in species are not only beneficial for the environment but also for people's general well-being.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Murali Macherla, MD Po Box 5877, Peoria, AZ 85385-5877 Ph: (510) 679-3980 | Dr Murali Macherla, MD 13640 N 99th Ave Ste 400, Sun City, AZ 85351-2867 Ph: (602) 999-9999 |
News Archive
Since the novel coronavirus SARS-Cov-2 emerged late last year, it has been virtually impossible to consume any news without encountering stories about the virus and how it spreads, potential treatments, and the development of new vaccines.
A type of anti-bacterial T cells, so-called MAIT cells, are strongly activated in people with moderate to severe COVID-19 disease, according to a study by researchers at Karolinska Institutet in Sweden that is published in the journal Science Immunology. The findings contribute to increased understanding about how our immune system responds against COVID-19 infection.
Medtronic plc announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the EvolveSM workflow*, which standardizes guidance and balances high-dose (HD) and low-dose (LD) therapy settings.
VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.
Researchers at the University of Sheffield have found that parks rich in species are not only beneficial for the environment but also for people's general well-being.
› Verified 6 days ago
Dr. Ryan Andrew Macke, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 13188 N 103rd Dr Ste 200, Sun City, AZ 85351 Phone: 623-832-3444 Fax: 623-832-3470 | |
Mr. Federico T. Florendo, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 13188 N 103rd Dr Ste 200, Sun City, AZ 85351 Phone: 623-875-6001 Fax: 623-875-8761 |